Advanced search
Publication Cover
Artificial Cells, Nanomedicine, and Biotechnology
An International Journal
Volume 47, 2019 - Issue 1
Submit an article Journal homepage
5,992
Views
23
CrossRef citations to date
0
Altmetric
Research Article

The 100 top-cited studies in cancer immunotherapy

Yonggang Zhanga Department of Periodical Press and National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, PR China;b Chinese Evidence-based Medicine Center, West China Hospital, Sichuan University, Chengdu, PR ChinaCorrespondence[email protected]
,
Liuliu Quanc West China School of Medicine, Sichuan University, Chengdu, PR China
&
Liang Dua Department of Periodical Press and National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, PR China;b Chinese Evidence-based Medicine Center, West China Hospital, Sichuan University, Chengdu, PR ChinaCorrespondence[email protected]
Pages 2282-2292 | Received 23 Mar 2019, Accepted 09 May 2019, Published online: 06 Jun 2019

Figures & data

Table 1. The 100 top-cited studies in cancer immunotherapy.

Table 2. Journals of the 100 top-cited studies published.

Table 3. Published years of the 100 top-cited studies.

Table 4. Study types of the 100 top-cited studies.

Table 5. Countries of the 100 top-cited studies.

Table 6. Institutions published at least two 100-top cited studies.

Table 7. Authors published at least two papers as first author or corresponding author.

Related Research Data

Progress in human tumour immunology and immunotherapy
Source: Springer Science and Business Media LLC
Monoclonal antibodies: versatile platforms for cancer immunotherapy.
Source: Springer Science and Business Media LLC
Treatment of 283 Consecutive Patients With Metastatic Melanoma or Renal Cell Cancer Using High-Dose Bolus Interleukin 2
Source: American Medical Association (AMA)
Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells.
Source: Springer Science and Business Media LLC
Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4
Source: American Association for the Advancement of Science (AAAS)
CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative
Source: Wiley
Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
Source: eScholarship, University of California
Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection.
Source: Proceedings of the National Academy of Sciences
Immunosuppressive networks in the tumour environment and their therapeutic relevance
Source: Springer Science and Business Media LLC
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
Source: The American Association of Immunologists
Cancer immunotherapy sweeps Nobel for medicine.
Source: American Association for the Advancement of Science (AAAS)
Immunological aspects of cancer chemotherapy.
Source: Springer Science and Business Media LLC
Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
Source: Massachusetts Medical Society
Basic Science Research Trends in Orthopedic Surgery: An Analysis of the Top 100 Cited Articles
Source: Springer Science and Business Media LLC
Cytokines in cancer pathogenesis and cancer therapy
Source: Springer Science and Business Media LLC
Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
Source: American Society of Clinical Oncology (ASCO)
A bibliometric analysis
Source: Ovid Technologies (Wolters Kluwer Health)
Natural Innate and Adaptive Immunity to Cancer
Source: Annual Reviews
Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma
Source: Springer Science and Business Media LLC
Top 100 cited systematic reviews and meta-analyses in dentistry.
Source: Informa UK Limited
Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment.
Source: Springer Science and Business Media LLC
Indoleamine 2,3-dioxygenase and tumor-induced tolerance.
Source: American Society for Clinical Investigation
Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells.
Source: Springer Science and Business Media LLC
Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma
Source: Springer Science and Business Media LLC
Cancer regression in patients after transfer of genetically engineered lymphocytes
Source: American Association for the Advancement of Science (AAAS)
Cancer immunotherapy comes of age
Source: Springer Science and Business Media LLC
T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
Source: American Association for the Advancement of Science (AAAS)
The 100 most-cited articles in neuroimaging: A bibliometric analysis.
Source: Elsevier BV
The 100 top-cited articles focused on magnetic resonance: a bibliometric analysis
Source: SAGE Publications
Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines: Physiologic and clinical implications
Source: Wiley
Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer.
Source: Massachusetts Medical Society
Prevalence of Regulatory T Cells Is Increased in Peripheral Blood and Tumor Microenvironment of Patients with Pancreas or Breast Adenocarcinoma
Source: The American Association of Immunologists
Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy
Source: Rockefeller University Press
Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
Source: American Society of Clinical Oncology (ASCO)
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
Source: Springer Science and Business Media LLC
Recombinant Human Interleukin-2, Recombinant Human Interferon Alfa-2a, or Both in Metastatic Renal-Cell Carcinoma
Source: Massachusetts Medical Society
B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor–transduced T cells
Source: American Society of Hematology
Adoptive immunotherapy for cancer: harnessing the T cell response
Source: Springer Science and Business Media LLC
The 100 top-cited studies on vaccine: a bibliometric analysis.
Source: Informa UK Limited
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma
Source: Proceedings of the National Academy of Sciences
Vaccination with Mage-3a1 Peptide–Pulsed Mature, Monocyte-Derived Dendritic Cells Expands Specific Cytotoxic T Cells and Induces Regression of Some Metastases in Advanced Stage IV Melanoma
Source: Rockefeller University Press
Sipuleucel-T immunotherapy for castration-resistant prostate cancer.
Source: Massachusetts Medical Society
A PRISMA-compliant systematic literature review and bibliometric analysis
Source: Ovid Technologies (Wolters Kluwer Health)
Cancer immunotherapy via dendritic cells
Source: Springer Vienna
Tumor-associated macrophages: from mechanisms to therapy.
Source: Elsevier BV
Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes.
Source: Rockefeller University Press
Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity.
Source: Elsevier BV
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
Source: American Society of Clinical Oncology (ASCO)
SWOT analysis and revelation in traditional Chinese medicine internationalization
Source: BMC
Cancer immunologists scoop medicine Nobel prize
Source: Springer Science and Business Media LLC
Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors
Source: Springer Science and Business Media LLC
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
Source: American Association for the Advancement of Science (AAAS)
Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.
Source: Rockefeller University Press
Immunosuppressive Strategies that are Mediated by Tumor Cells
Source: Annual Reviews
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
Source: Proceedings of the National Academy of Sciences
Placebo-Controlled Phase III Trial of Immunologic Therapy with Sipuleucel-T (APC8015) in Patients with Metastatic, Asymptomatic Hormone Refractory Prostate Cancer
Source: American Society of Clinical Oncology (ASCO)
Neoantigens in cancer immunotherapy
Source: American Association for the Advancement of Science (AAAS)
Immune surveillance of tumors.
Source: American Society for Clinical Investigation
The top 100 most cited scientific reports focused on diabetes research.
Source: Springer Science and Business Media LLC
The 100 most cited articles in dentistry
Source: Springer Science and Business Media LLC
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
Source: Springer Science and Business Media LLC
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Source: Massachusetts Medical Society
Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
Source: Ovid Technologies (Wolters Kluwer Health)
Top 100 Most Influential Articles in the Field of Myeloid Neoplasms: A Bibliometric Study.
Source: S. Karger AG
Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial
Source: Elsevier BV

Linking provided by 

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.